Clinical trial
Double GnRH Antagonist Daily Dose in Hyperresponding IVF/ICSI Cycles May Prevent the OHSS
NCT01477970 is registered in ClinicalTrials.gov with Iakentro Fertility Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double GnRH Antagonist Daily Dose in Hyperresponding IVF/ICSI Cycles May Prevent the OHSS
- Lead sponsor
- Iakentro Fertility Centre
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2009
- Completion date
- February 28, 2010
- Enrollment
- 38 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.